Literature DB >> 29851508

Vascular Adaptation of the Right Ventricle in Experimental Pulmonary Hypertension.

Brian B Graham1, Rahul Kumar1, Claudia Mickael1, Biruk Kassa1, Dan Koyanagi1, Linda Sanders1, Li Zhang1, Mario Perez1, Daniel Hernandez-Saavedra1, Carolyn Valencia1, Kandice Dixon2, Julie Harral2, Zoe Loomis2, David Irwin2, Travis Nemkov3, Angelo D'Alessandro3, Kurt R Stenmark2, Rubin M Tuder1.   

Abstract

Optimal right ventricular (RV) function in pulmonary hypertension (PH) requires structural and functional coupling between the RV cardiomyocyte and its adjacent capillary network. Prior investigations have indicated that RV vascular rarefaction occurs in PH, which could contribute to RV failure by reduced delivery of oxygen or other metabolic substrates. However, it has not been determined if rarefaction results from relative underproliferation in the setting of tissue hypertrophy or from actual loss of vessels. It is also unknown if rarefaction results in inadequate substrate delivery to the RV tissue. In the present study, PH was induced in rats by SU5416-hypoxia-normoxia exposure. The vasculature in the RV free wall was assessed using stereology. Steady-state metabolomics of the RV tissue was performed by mass spectrometry. Complementary studies were performed in hypoxia-exposed mice and rats. Rats with severe PH had evidence of RV failure by decreased cardiac output and systemic hypotension. By stereology, there was significant RV hypertrophy and increased total vascular length in the RV free wall in close proportion, with evidence of vessel proliferation but no evidence of endothelial cell apoptosis. There was a modest increase in the radius of tissue served per vessel, with decreased arterial delivery of metabolic substrates. Metabolomics revealed major metabolic alterations and metabolic reprogramming; however, metabolic substrate delivery was functionally preserved, without evidence of either tissue hypoxia or depletion of key metabolic substrates. Hypoxia-treated rats and mice had similar but milder alterations. There is significant homeostatic vascular adaptation in the right ventricle of rodents with PH.

Entities:  

Keywords:  angiogenesis; metabolism; pulmonary hypertension; right ventricle

Mesh:

Substances:

Year:  2018        PMID: 29851508      PMCID: PMC6178158          DOI: 10.1165/rcmb.2018-0095OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   7.748


  44 in total

1.  Role of PFKFB3-driven glycolysis in vessel sprouting.

Authors:  Katrien De Bock; Maria Georgiadou; Sandra Schoors; Anna Kuchnio; Brian W Wong; Anna Rita Cantelmo; Annelies Quaegebeur; Bart Ghesquière; Sandra Cauwenberghs; Guy Eelen; Li-Kun Phng; Inge Betz; Bieke Tembuyser; Katleen Brepoels; Jonathan Welti; Ilse Geudens; Inmaculada Segura; Bert Cruys; Franscesco Bifari; Ilaria Decimo; Raquel Blanco; Sabine Wyns; Jeroen Vangindertael; Susana Rocha; Russel T Collins; Sebastian Munck; Dirk Daelemans; Hiromi Imamura; Roland Devlieger; Mark Rider; Paul P Van Veldhoven; Frans Schuit; Ramon Bartrons; Johan Hofkens; Peter Fraisl; Sucheta Telang; Ralph J Deberardinis; Luc Schoonjans; Stefan Vinckier; Jason Chesney; Holger Gerhardt; Mieke Dewerchin; Peter Carmeliet
Journal:  Cell       Date:  2013-08-01       Impact factor: 41.582

Review 2.  Emerging role of angiogenesis in adaptive and maladaptive right ventricular remodeling in pulmonary hypertension.

Authors:  Andrea L Frump; Sébastien Bonnet; Vinicio A de Jesus Perez; Tim Lahm
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-11-02       Impact factor: 5.464

3.  Outcome of adults with Eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension: A French multicentre study.

Authors:  Sebastien Hascoet; Emmanuelle Fournier; Xavier Jaïs; Lauriane Le Gloan; Claire Dauphin; Ali Houeijeh; Francois Godart; Xavier Iriart; Adelaïde Richard; Jelena Radojevic; Pascal Amedro; Gilles Bosser; Nathalie Souletie; Yvette Bernard; Pamela Moceri; Hélène Bouvaist; Pierre Mauran; Elise Barre; Adeline Basquin; Clement Karsenty; Damien Bonnet; Laurence Iserin; Olivier Sitbon; Jérôme Petit; Elie Fadel; Marc Humbert; Magalie Ladouceur
Journal:  Arch Cardiovasc Dis       Date:  2017-03-09       Impact factor: 2.340

4.  Transforming growth factor-β signaling promotes pulmonary hypertension caused by Schistosoma mansoni.

Authors:  Brian B Graham; Jacob Chabon; Liya Gebreab; Jennifer Poole; Elias Debella; Laura Davis; Takeshi Tanaka; Linda Sanders; Nina Dropcho; Angela Bandeira; R William Vandivier; Hunter C Champion; Ghazwan Butrous; Xiao-Jing Wang; Thomas A Wynn; Rubin M Tuder
Journal:  Circulation       Date:  2013-08-19       Impact factor: 29.690

5.  Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension.

Authors:  Lin Piao; Yong-Hu Fang; Kishan Parikh; John J Ryan; Peter T Toth; Stephen L Archer
Journal:  J Mol Med (Berl)       Date:  2013-06-21       Impact factor: 4.599

6.  Clonal Expansion of Endothelial Cells Contributes to Ischemia-Induced Neovascularization.

Authors:  Yosif Manavski; Tina Lucas; Simone F Glaser; Lena Dorsheimer; Stefan Günther; Thomas Braun; Michael A Rieger; Andreas M Zeiher; Reinier A Boon; Stefanie Dimmeler
Journal:  Circ Res       Date:  2018-01-22       Impact factor: 17.367

7.  Hypoxia-dependent reduction of 1-(2-nitro-1-imidazolyl)-3-methoxy-2-propanol by Chinese hamster ovary cells and KHT tumor cells in vitro and in vivo.

Authors:  A J Varghese; S Gulyas; J K Mohindra
Journal:  Cancer Res       Date:  1976-10       Impact factor: 12.701

8.  Fasting 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography to detect metabolic changes in pulmonary arterial hypertension hearts over 1 year.

Authors:  Erika L Lundgrin; Margaret M Park; Jacqueline Sharp; W H Wilson Tang; James D Thomas; Kewal Asosingh; Suzy A Comhair; Frank P DiFilippo; Donald R Neumann; Laura Davis; Brian B Graham; Rubin M Tuder; Iva Dostanic; Serpil C Erzurum
Journal:  Ann Am Thorac Soc       Date:  2013-02

9.  Temporal hemodynamic and histological progression in Sugen5416/hypoxia/normoxia-exposed pulmonary arterial hypertensive rats.

Authors:  Michie Toba; Abdallah Alzoubi; Kealan D O'Neill; Salina Gairhe; Yuri Matsumoto; Kaori Oshima; Kohtaro Abe; Masahiko Oka; Ivan F McMurtry
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-15       Impact factor: 4.733

10.  Cardiac remodelling amongst adults with various aetiologies of pulmonary arterial hypertension including Eisenmenger syndrome-implications on survival and the role of right ventricular transverse strain.

Authors:  Pamela Moceri; Priscille Bouvier; Delphine Baudouy; Konstantinos Dimopoulos; Pierre Cerboni; Stephen J Wort; Denis Doyen; Elie-Dan Schouver; Pierre Gibelin; Roxy Senior; Michael A Gatzoulis; Emile Ferrari; Wei Li
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2017-11-01       Impact factor: 6.875

View more
  16 in total

1.  Redox Biology of Peroxisome Proliferator-Activated Receptor-γ in Pulmonary Hypertension.

Authors:  Victor Tseng; Roy L Sutliff; C Michael Hart
Journal:  Antioxid Redox Signal       Date:  2019-02-25       Impact factor: 8.401

2.  Band on the run: insights into right ventricular reverse remodelling.

Authors:  Robert D Brown; Mehdi A Fini; Kurt R Stenmark
Journal:  Cardiovasc Res       Date:  2020-08-01       Impact factor: 10.787

3.  The role of macrophages in right ventricular remodeling in experimental pulmonary hypertension.

Authors:  Sue Gu; Claudia Mickael; Rahul Kumar; Michael H Lee; Linda Sanders; Biruk Kassa; Julie Harral; Jason Williams; Kirk C Hansen; Kurt R Stenmark; Rubin M Tuder; Brian B Graham
Journal:  Pulm Circ       Date:  2022-07-01       Impact factor: 2.886

4.  Loss of Amphiregulin drives inflammation and endothelial apoptosis in pulmonary hypertension.

Authors:  Jonathan Florentin; Jingsi Zhao; Yi-Yin Tai; Wei Sun; Lee L Ohayon; Scott P O'Neil; Anagha Arunkumar; Xinyi Zhang; Jianhui Zhu; Yassmin Al Aaraj; Annie Watson; John Sembrat; Mauricio Rojas; Stephen Y Chan; Partha Dutta
Journal:  Life Sci Alliance       Date:  2022-06-22

5.  Hot topics in the mechanisms of pulmonary arterial hypertension disease: cancer-like pathobiology, the role of the adventitia, systemic involvement, and right ventricular failure.

Authors:  Edda Spiekerkoetter; Elena A Goncharova; Christophe Guignabert; Kurt Stenmark; Grazyna Kwapiszewska; Marlene Rabinovitch; Norbert Voelkel; Harm J Bogaard; Brian Graham; Soni S Pullamsetti; Wolfgang M Kuebler
Journal:  Pulm Circ       Date:  2019-11-20       Impact factor: 3.017

6.  Metabolic Reprogramming in the Heart and Lung in a Murine Model of Pulmonary Arterial Hypertension.

Authors:  Jose L Izquierdo-Garcia; Teresa Arias; Yeny Rojas; Victoria Garcia-Ruiz; Arnoldo Santos; Silvia Martin-Puig; Jesus Ruiz-Cabello
Journal:  Front Cardiovasc Med       Date:  2018-08-15

Review 7.  Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.

Authors:  Sasha Z Prisco; Thenappan Thenappan; Kurt W Prins
Journal:  JACC Basic Transl Sci       Date:  2020-12-28

8.  Endothelial cell PHD2-HIF1α-PFKFB3 contributes to right ventricle vascular adaptation in pulmonary hypertension.

Authors:  Biruk Kassa; Rahul Kumar; Claudia Mickael; Linda Sanders; Christine Vohwinkel; Michael H Lee; Sue Gu; Jens M Poth; Kurt R Stenmark; You-Yang Zhao; Rubin M Tuder; Brian B Graham
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-08-04       Impact factor: 6.011

9.  Pediatric Pulmonary Hypertension: Definitions, Mechanisms, Diagnosis, and Treatment.

Authors:  Devashis Mukherjee; Girija G Konduri
Journal:  Compr Physiol       Date:  2021-06-30       Impact factor: 8.915

10.  Acetazolamide Improves Right Ventricular Function and Metabolic Gene Dysregulation in Experimental Pulmonary Arterial Hypertension.

Authors:  Fotios Spyropoulos; Zoe Michael; Benjamin Finander; Sally Vitali; Kosmas Kosmas; Panagiotis Zymaris; Brian T Kalish; Stella Kourembanas; Helen Christou
Journal:  Front Cardiovasc Med       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.